Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$52.10 – $71.75
43% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $14.39B | $14.37B | $14.01B | $14.95B | $17.55B | $17.91B | $3.83B | $4.16B |
| Cost of revenue | $6.09B | $6.39B | $6.16B | $6.31B | $7.96B | $8.18B | $1.84B | $1.92B |
| Gross profit | $8.30B | $7.99B | $7.85B | $8.64B | $9.59B | $9.73B | $1.99B | $2.24B |
| Gross margin | 57.7% | 55.6% | 56.0% | 57.8% | 54.6% | 54.3% | 52.0% | 53.9% |
| R&D | $1.86B | $1.97B | $1.94B | $2.01B | $2.00B | $2.02B | $412.9M | −$57.8M |
| Operating income | $4.07B | $4.04B | $3.65B | $4.01B | $4.56B | $3.98B | $500.6M | $882.6M |
| EBITDA | $5.10B | $4.58B | $4.70B | $5.06B | $5.72B | $5.64B | $1.08B | $1.39B |
| Net income | $3.23B | $3.15B | $2.83B | $3.15B | $3.68B | $3.03B | $305.6M | $583.6M |
| Net margin | 22.4% | 21.9% | 20.2% | 21.0% | 20.9% | 16.9% | 8.0% | 14.0% |
| EPS (diluted) | 11.03 | 11.01 | 10.02 | 11.23 | 13.19 | 10.88 | 0.67 | 1.25 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $33.0B | $15.05 | $14.53–$15.55 | 4 |
| 2027 | $35.4B | $16.67 | $16.09–$17.22 | 4 |
| 2028 | $38.0B | $18.48 | $17.84–$19.09 | 5 |
| 2029 | $40.8B | $21.77 | $21.02–$22.49 | 4 |
Forward consensus · source: Financial Modeling Prep
NOVONESIS A S
No one on the platform currently holds NVZMF.
No tracked institution reports a position in NVZMF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-03-25 | $4.2500 | 2026-03-26 |
| 2025-08-22 | $2.2500 | 2025-08-27 |
| 2025-04-07 | $4.2000 | 2025-04-08 |
| 2024-08-30 | $2.0000 | 2024-09-03 |
| 2024-05-01 | $2.0000 | 2024-05-03 |
| 2023-10-11 | $4.2000 | 2023-10-19 |
| Execution date | Ratio |
|---|---|
| 2011-11-28 | 5-for-1 |
No one on the platform has traded NVZMF yet.
| $34.8B |
| — |
| APDAir Products and Chemicals, Inc. | $293.18 | +8.04% | $65.3B | — |
| AVOAAvoca LLC | $1205.00 | +0.00% | $10M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 53.6× earnings vs its 7.3× historical median P/E.
Fair value ≈ $8.28 · price $60.60 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.